Which of the following treatments is used to manage symptoms and slow the deterioration in lung health for cystic fibrosis patients?

The use of ibuprofen in managing cystic fibrosis symptoms is primarily due to its anti-inflammatory properties. In cystic fibrosis, inflammation of the airways is a significant concern due to chronic lung infections and mucus obstruction. Regular use of high-dose ibuprofen has been shown to help reduce airway inflammation, which can improve lung function and slow the decline in pulmonary health for patients with this genetic disorder. Additionally, ibuprofen may help enhance the overall quality of life for cystic fibrosis patients by decreasing inflammation and subsequently the frequency of respiratory exacerbations.

While other treatment options such as antibiotics and steroids play important roles in managing infections and inflammation in cystic fibrosis patients, they do not specifically target the chronic inflammation in the airways in the same way that ibuprofen does. Antibiotics are critical for treating bacterial infections, steroids can help with acute exacerbations, and oral hydration is important for overall health, but they do not singularly address the underlying inflammatory process in the lungs associated with cystic fibrosis as effectively as ibuprofen can. Thus, ibuprofen stands out as a key treatment for managing symptoms and slowing lung health deterioration in these patients.